Atlas Trials

Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients

Clinical trial NCT07321808 · RECRUITING

Trial details

NCT number
NCT07321808
Sponsor
Fondazione IRCCS Policlinico San Matteo di Pavia
Status
RECRUITING
Study type
OBSERVATIONAL
Immunocompromised Patients
Start date
2023-05-16
Primary completion
2027-05-01
Enrollment
300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.